ClinicalTrials.Veeva

Menu

Internet-based Support for Adjustment to Prostate Cancer (ISAC)

L

Linköping University (LiU)

Status

Enrolling

Conditions

Insomnia
Anxiety
Prostate Cancer
Depression - Major Depressive Disorder
Psychological Distress

Treatments

Behavioral: Internet-based cognitive behavioral therapy
Behavioral: Non-directive support

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.

Full description

Men diagnosed with prostate cancer frequently suffer from a wide range of psychological problems that can be traced to their disorder. Examples include depressed mood and worry regarding the prognosis and/or cancer recurrence. Psychological treatments can be used for helping cancer patients deal with this kind of distress, but frequently only targets one kind of symptoms.

This study investigates a tailored approach to providing help for men diagnosed with prostate cancer. Participants randomized to the treatment condition will receive an eight week ICBT intervention which is tailored to the problem profile of the participant in question. The treatment will last eight weeks and participants will receive weekly support and feedback from a therapist. Participants randomized to the control condition will receive weekly therapist support, but not access to the treatment modules. The primary outcome of interest is psychological distress, and other health-related outcomes will be measured as well. Participants will be recruited in Sweden with a nationwide recruitment.

Enrollment

180 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis.
  • A sum score above 19 on the primary outcome measure (Kessler-10).
  • An age of 18 or older.
  • Ability to speak, read, and write Swedish.
  • Access to a computer/laptop/tablet/smartphone and internet access.
  • Sufficient computer profiency to be able to use the treatment platform.

Exclusion criteria

  • Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period.
  • Recently finished (within the past six months) medical treatment for prostate cancer.
  • Severe psychiatric or somatic conditions that impedes participation in the study.
  • Ongoing substance use problems.
  • Acute suicidality.
  • Other ongoing psychological treatment.
  • Psychopharmaceutic treatment that has been changed within the past month or with planned changes during the treatment phase.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

180 participants in 2 patient groups

Tailored ICBT
Experimental group
Description:
An eight week long ICBT treatment that is tailored to the problem profile of the participant. The treatment is modular, with one module being administered per week of the treatment.
Treatment:
Behavioral: Internet-based cognitive behavioral therapy
Non-directive support
Active Comparator group
Description:
The control group will receive weekly support via contact with a therapist, without receiving access to the treatment modules.
Treatment:
Behavioral: Non-directive support

Trial contacts and locations

1

Loading...

Central trial contact

Gerhard Andersson, Ph.D.; Anton Käll, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems